
Spectrum Pharmaceuticals SPPI
Quartalsbericht 2023-Q1
hinzugefügt 11.05.2023
Spectrum Pharmaceuticals P/CF 2011-2026 | SPPI
P/CF Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.27 | -0.881 | -3.51 | -2.02 | -17.8 | -48.6 | -8.07 | 49.4 | -99.3 | -99.7 | 15.1 | 17.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 49.4 | -99.7 | -16.6 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Ultragenyx Pharmaceutical
RARE
|
-4.32 | $ 19.23 | -3.85 % | $ 1.9 B | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
RedHill Biopharma Ltd.
RDHL
|
-18.5 | $ 0.8 | 0.89 % | $ 428 M | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
0.302 | $ 13.56 | -1.56 % | $ 2.25 B | ||
|
Regeneron Pharmaceuticals
REGN
|
16.3 | $ 742.02 | -1.94 % | $ 77.6 B | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Replimune Group
REPL
|
-3.13 | $ 7.22 | -4.24 % | $ 582 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
REGENXBIO
RGNX
|
-3.58 | $ 7.88 | -4.6 % | $ 406 M | ||
|
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | ||
|
Rigel Pharmaceuticals
RIGL
|
7.9 | $ 26.2 | -0.64 % | $ 471 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | ||
|
Avidity Biosciences
RNA
|
-15.4 | $ 13.09 | -0.08 % | $ 1.8 B | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Avid Bioservices
CDMO
|
38.7 | - | - | $ 789 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
-54.8 | $ 78.52 | -4.13 % | $ 5.1 B | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-54 | $ 12.57 | -9.96 % | $ 1.91 B | ||
|
Sana Biotechnology
SANA
|
-6.92 | $ 2.78 | -8.42 % | $ 704 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
SIGA Technologies
SIGA
|
9.3 | $ 5.35 | 7.76 % | $ 383 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
77.9 | $ 321.71 | -1.96 % | $ 42.1 B | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
-0.588 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
-0.024 | - | - | $ 3.74 B | ||
|
Silence Therapeutics plc
SLN
|
239 | $ 4.8 | -9.6 % | $ 622 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-1.4 | $ 1.08 | -0.92 % | $ 22.2 M | ||
|
Enochian Biosciences
ENOB
|
-14.7 | - | - | $ 40.5 M |